Overexpression of human osteopontin increases cell proliferation and migration in human embryo kidney-293 cells

Cellular and Molecular Biology Letters

Volumn 14, Issue 4, 2009, Pages 670-678

  Liu, Ya Jun ^a   Zhang, Dao Qiang ^b   Sui, Xiu Mei ^b   Tian, Wei ^a  

^a PEKING UNIVERSITY   (China)

^b WEIFANG MEDICAL UNIVERSITY   (China)

Author keywords

Metastasis; Osteopontin; Overexpression; Proliferation

Indexed keywords

OSTEOPONTIN;

ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL GROWTH; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL STRAIN HEK293; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; METASTASIS; PROTEIN EXPRESSION; CELL CYCLE; CELL LINE; CELL MOTION; CYTOLOGY; GENE EXPRESSION; GENETICS; KIDNEY; METABOLISM; PRENATAL DEVELOPMENT;

CELL CYCLE; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION; HUMANS; KIDNEY; OSTEOPONTIN;

EID: 70349902884     PISSN: 14258153     EISSN: 16891392     Source Type: Journal    
DOI: 10.2478/s11658-009-0027-z     Document Type: Article

References (24)

1. Ramaiah, S.K. and Rittling, S. Pathophysiological role of osteopontin in hepatic inflammation, toxicity, and cancer. Toxicol. Sci. 103 (2008) 4-13.
2. Rangaswami, H., Bulbule, A. and Kundu, G.C. Osteopontin: role in cell signaling and cancer progression. Trends Cell Biol. 16 (2006) 79-87.
3. Rittling, S.R. and Chambers, A.F. Role of osteopontin in tumour progression. Br. J. Cancer 90 (2004) 1877-1881.
4. Haqq, C., Nosrati, M., Sudilovsky, D., Crothers, J., Khodabakhsh, D., Pulliam, B.L., Federman, S., Miller, J.R., 3rd, Allen, R.E., Singer, M.I., Leong, S.P., Ljung, B.M., Sagebiel, R.W. and Kashani-Sabet, M. The gene expression signatures of melanoma progression. Proc. Natl. Acad. Sci. USA 102 (2005) 6092-6097.
5. Fedarko, N.S., Jain, A., Karadag, A., Van Eman, M.R. and Fisher, L.W. Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer. Clin. Cancer Res. 7 (2001) 4060-4066. (Pubitemid 34044628)
6. Wai, P.Y. and Kuo, P.C. The role of Osteopontin in tumor metastasis. J. Surg. Res. 121 (2004) 228-241.
7. Coppola, D., Szabo, M., Boulware, D., Muraca, P., Alsarraj, M., Chambers, A.F. and Yeatman, T.J. Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies. Clin. Cancer Res. 10 (2004) 184-190. (Pubitemid 38114178)
8. Rodrigues, L.R., Teixeira, J.A., Schmitt, F.L., Paulsson, M. and Lindmark- Mansson, H. The role of osteopontin in tumor progression and metastasis in breast cancer. Cancer Epidemiol. Biomarkers Prev. 16 (2007) 1087-1097. (Pubitemid 46984943)
9. Suzuki, M., Mose, E., Galloy, C. and Tarin, D. Osteopontin gene expression determines spontaneous metastatic performance of orthotopic human breast cancer xenografts. Am. J. Pathol. 171 (2007) 682-692. (Pubitemid 47344699)
10. Standal, T., Borset, M. and Sundan, A. Role of osteopontin in adhesion, migration, cell survival and bone remodeling. Exp. Oncol. 26 (2004) 179-184. (Pubitemid 39424636)
11. Furger, K.A., Menon, R.K., Tuck, A.B., Bramwell, V.H. and Chambers, A.F. The functional and clinical roles of osteopontin in cancer and metastasis. Curr. Mol. Med. 1 (2001) 621-632. (Pubitemid 33772040)
12. Chatterjee, S.K. and Zetter, B.R. Cancer biomarkers: knowing the present and predicting the future. Future Oncol. 1 (2005) 37-50.
13. El-Tanani, M.K., Campbell, F.C., Kurisetty, V., Jin, D., McCann, M. and Rudland, P.S. The regulation and role of osteopontin in malignant transformation and cancer. Cytokine Growth Factor Rev. 17 (2006) 463-474. (Pubitemid 44793123)
14. Johnston, N.I., Gunasekharan, V.K., Ravindranath, A., O'Connell, C., Johnston, P.G. and El-Tanani, M.K. Osteopontin as a target for cancer therapy. Front Biosci. 13 (2008) 4361-4372.
15. Mustafa, H., Strasser, B., Rauth, S., Irving, R.A. and Wark, K.L. Identification of a functional nuclear export signal in the green fluorescent protein asFP499. Biochem. Biophys. Res. Commun. 342 (2006) 1178-1182.
16. Elgavish, A., Prince, C., Chang, P.L., Lloyd, K., Lindsey, R. and Reed, R. Osteopontin stimulates a subpopulation of quiescent human prostate epithelial cells with high proliferative potential to divide in vitro. Prostate 35 (1998) 83-94. (Pubitemid 28183290)
17. Scatena, M., Almeida, M., Chaisson, M.L., Fausto, N., Nicosia, R.F. and Giachelli, C.M. NF-kappaB mediates alphavbeta3 integrin-induced endothelial cell survival. J. Cell Biol. 141 (1998) 1083-1093. (Pubitemid 28243974)
18. Chambers, A.F. and Tuck, A.B. Ras-responsive genes and tumor metastasis. Crit. Rev. Oncog. 4 (1993) 95-114.
19. Wai, P.Y., Mi, Z., Guo, H., Sarraf-Yazdi, S., Gao, C., Wei, J., Marroquin, C.E., Clary, B. and Kuo, P.C. Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis. Carcinogenesis 26 (2005) 741-751. (Pubitemid 41214336)
20. Wu, Y., Denhardt, D.T. and Rittling, S.R. Osteopontin is required for full expression of the transformed phenotype by the ras oncogene. Br. J. Cancer 83 (2000) 156-163. (Pubitemid 30411711)
21. Denhardt, D. Osteopontin expression correlates with melanoma invasion. J. Invest. Dermatol. 124 (2005) xvi-xviii. (Pubitemid 40629082)
22. Geissinger, E., Weisser, C., Fischer, P., Schartl, M. and Wellbrock, C. Autocrine stimulation by osteopontin contributes to antiapoptotic signalling of melanocytes in dermal collagen. Cancer Res. 62 (2002) 4820-4828. (Pubitemid 34898612)
23. Bogenrieder, T. and Herlyn, M. Axis of evil: molecular mechanisms of cancer metastasis. Oncogene 22 (2003) 6524-6536. (Pubitemid 37372332)
24. Cook, A.C., Chambers, A.F., Turley, E.A. and Tuck, A.B. Osteopontin induction of hyaluronan synthase 2 expression promotes breast cancer malignancy. J. Biol. Chem. 281 (2006) 24381-24389.